Huadong Medicine’s MediBeacon TGFR System Approved by NMPA for GFR Measurement
China-based Huadong Medicine Co., Ltd (SHE: 000963) announced that it has received marketing approval from...
Sunshine Guojian and Shenyang 3SBio License 612 and 708 Programs for Anti-Tumor Development
China-based Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd and Shenyang 3SBio Co., Ltd, both subsidiaries of...
Antengene to Boost T Cell Engager Platform with AI Investment and DeepSeek Deployment
China-based biopharma Antengene Corp., Ltd (HKG: 6996) announced plans to increase investment in establishing a...
Jiangxi Rimag Group and Xunfei Healthcare Form Strategic Alliance for Smart Healthcare
China-based Jiangxi Rimag Group Co., Ltd (HKG: 2522) announced a strategic alliance with Xunfei Healthcare...
Rendu Biotechnology Partners with Green Apple Medical System for RNA Diagnostics Expansion
Rendu Biotechnology Co., Ltd., (SHA: 688193) a Shanghai-based specialist in RNA molecular diagnostics, has entered...
Genuine Biotech Files for Hong Kong IPO with Azvudine and ZS-1003 in Pipeline
China-based Genuine Biotech Limited has filed for an initial public offering (IPO) on the Hong...
AstraZeneca Faces Class Action Lawsuits Over China Legal Issues
AstraZeneca plc (AZ, NASDAQ: AZN) is facing multiple class action lawsuits in the United States...
Biogen Licenses Stoke Therapeutics’ Zorevunersen for Dravet Syndrome Outside Americas
US-based Biogen Inc. (NASDAQ: BIIB) has entered into a licensing agreement with Stoke Therapeutics, Inc....
TAHO Pharma’s TAH3311 Oral Film Shows Bioequivalence to Eliquis in Study
Taiwan-based TAHO Pharmaceuticals announced positive preliminary results from a pivotal study for its TAH3311 oral...
Sanofi’s Dupixent Receives Priority Review from FDA for Bullous Pemphigoid Treatment
Sanofi (EPA: SAN, NASDAQ: SNY) announced that the US Food and Drug Administration (FDA) has...
CSPC Pharma Licenses SYS 6005 to Radiance Biopharma for Global Markets
China-based CSPC Pharmaceutical Group Ltd (HKG: 1093) announced a licensing agreement with Radiance Biopharma, Inc.,...
Biokin Pharmaceutical’s BL-M07D1 Receives NMPA Approval for Phase II/III Study in HER2+ Breast Cancer
China-based Sichuan Biokin Pharmaceutical Co., Ltd (SHA: 688506) announced that it has received approval from...
Gilead Sciences’ Lenacapavir NDA for HIV Prevention Accepted by FDA for Priority Review
US-based Gilead Sciences Inc. (NASDAQ: GILD) announced that the New Drug Application (NDA) for its...
Merck’s Welireg Wins Conditional EU Approval for VHL Disease and Advanced RCC
US pharmaceutical giant Merck, Sharp & Dohme (MSD, NYSE: MRK) announced that it has received...
GSK and Abbott Announce Leadership Changes in Key Roles
Recent days have seen significant leadership changes at two pharmaceutical giants: UK-based GSK plc (LON:...
Medtronic Q3 Earnings Show 4.1% Organic Growth, Driven by Cardiac Ablation
US-Irish medical device company Medtronic (NYSE: MDT) reported financial results for the third quarter (Q3)...
QuantumPharm and Hengjian Launch GBA AI+ Innovation Consortium
Shenzhen-based QuantumPharm Inc. (HKG: 2228), also known as Xtalpi Inc., and Guangdong Hengjian Investment Holding...
Deepwise Information Integrates DeepSeek into Medical Data Platform
Deepwise Information, a leading artificial intelligence company in the medical field, has fully integrated its...
Weimai Qingtong Medical Technology Completes Tens of Millions Yuan B+ Round
Weimai Qingtong Medical Technology (WEMT), a medical device company based in Wuxi, has completed a...
InnoCare Pharma Receives NMPA Approval for Mesutoclax Phase III Study in CLL/SLL
Beijing-based biotech InnoCare Pharma (HKG: 9969, SHA: 688428) announced that it has received approval from...